A Universal HPLC Determination of Insulin Potency
- 1 March 1985
- journal article
- research article
- Published by Taylor & Francis in Journal of Liquid Chromatography
- Vol. 8 (3) , 419-439
- https://doi.org/10.1080/01483918508067090
Abstract
A liquid chromatographic method for determination of insulin potency is presented. It is applicable to bovine, porcine and human insulins, and to both insulin crystals and insulin formulations. The method uses a unique standard preparation (40 U/ml in 0.6 mg/ml EDTA) which is stable enough to permit use for > 1 mo. Likewise, samples are prepared in a stable form, so that an autoinjector may be used. NPH insulin suspensions are clarified by addition of heparin, lente insulins are clarified by addition of tetrasodium EDTA, and EDTA is added to neutral regular insulins and insulin crystals. Chromatography was done using a previously described 0.2 M pH 2.0 phosphate/26% CH3CN mobile phase and a reversed phase column. A 3-laboratory study of the method found it to have a precision of .+-. 2% for formulation assays. It was verified to be accurate by comparison with the traditional rabbit biopotency assay, over which the liquid chromatographic assay has several significant advantages.This publication has 5 references indexed in Scilit:
- Reversed-phase high-performance liquid chromatography of insulins from different speciesJournal of Chromatography A, 1983
- Analysis of insulin preparations by reversed-phase high-performance liquid chromatographyJournal of Chromatography A, 1982
- Role of the organic solvent modifier in the reversed phase high-performance liquid chromatography of polypeptidesChromatographia, 1981
- Applications of chromatography in the standardization and control of biological productsJournal of Chromatography A, 1978
- Historical review of the analytical control of insulinThe Analyst, 1974